Related Experiment Video
Updated: Aug 8, 2026

A Model of Chronic Nutrient Infusion in the Rat
Published on: August 14, 2013
Development of gluconeogenesis in neonatal rat liver. Effect of triamcinolone
D Yeung1, R S Stanley, I T Oliver
1Department of Biochemistry, University of Western Australia, Nedlands, W.A., Australia.
Insights
Glucocorticoids like triamcinolone do not initiate gluconeogenic enzyme synthesis in developing rat liver. While some enzyme activities are altered, key enzymes like phosphopyruvate carboxylase appear postnatally, independent of steroid exposure.
Area of Science:
- Biochemistry
- Developmental Biology
- Endocrinology
Background:
- Gluconeogenesis is critical for neonatal glucose homeostasis.
- Enzyme development in rat liver during the neonatal period is crucial for metabolic adaptation.
- The role of glucocorticoids in regulating the expression of gluconeogenic enzymes during development is not fully understood.
Purpose of the Study:
- To investigate the developmental profiles of key gluconeogenic enzymes in neonatal rat liver.
- To examine the effects of the synthetic glucocorticoid triamcinolone on these enzymes during fetal development.
Main Methods:
- Measurement of enzyme activities (glucose 6-phosphatase, hexose diphosphatase, phosphopyruvate carboxylase, pyruvate carboxylase) in fetal and neonatal rat liver.
- Administration of triamcinolone to pregnant rats to assess its impact on fetal liver enzyme development.
- Analysis of other enzyme activities (pyruvate kinase, aspartate amino-transferase, phosphofructokinase, tyrosine amino-transferase) following triamcinolone exposure.
Main Results:
- Key gluconeogenic enzymes are present in late fetal liver with increased activity postnatally.
- Phosphopyruvate carboxylase activity appears immediately after birth, peaking by day four.
- Triamcinolone administration depressed glucose 6-phosphatase and hexose diphosphatase, but did not affect pyruvate carboxylase or cause premature phosphopyruvate carboxylase appearance.
Conclusions:
- Glucocorticoids do not initiate the synthesis of gluconeogenic enzymes in developing rat liver.
- The observed effects of triamcinolone suggest a modulatory role rather than an inductive one on these enzymes.
- Enzyme development during the neonatal period is a complex process influenced by multiple factors beyond glucocorticoid signaling.
Abstract:
1. The normal development of the key enzymes of gluconeogenesis in rat liver, glucose 6-phosphatase, hexose diphosphatase, phosphopyruvate carboxylase and pyruvate carboxylase, was measured during the neonatal period. 2. Glucose 6-phosphatase, hexose diphosphatase and pyruvate carboxylase are all present in the late foetal liver, but all the enzymes show an increase in activity after birth. 3. Phosphopyruvate carboxylase is not present in liver extracts from foetal rats, but activity appears immediately after birth and increases rapidly over the first day and then more slowly to reach its maximum at the fourth postnatal day. 4. The fluorinated synthetic glucocorticoid, triamcinolone, was administered to foetal rats at various gestation times by intraperitoneal injection in utero and the animals were killed at intervals between 4 and 48hr. later. 5. The administration of triamcinolone results in slight depression of glucose 6-phosphatase, and a more significant depression of hexose diphosphatase to about one-half its normal activity in foetal rat liver. 6. Triamcinolone injection is without effect on pyruvate carboxylase activity and does not result in premature appearance of phosphopyruvate carboxylase in foetal rat liver. 7. Pyruvate kinase and aspartate amino-transferase activities in foetal rat liver are both depressed by triamcinolone treatment, whereas phosphofructokinase activity is elevated. 8. Tyrosine amino-transferase activity in foetal rat liver is markedly elevated in animals exposed to triamcinolone for 10hr. or more, but the effect is only observed in animals close to term. 9. The results are discussed in relation to mechanisms involved in the initial synthesis of tissue-specific enzymes in developing tissues, and it is concluded that glucocorticoids do not initiate the synthesis of the gluconeogenic enzymes.
More Related Videos
08:58Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014